198 related articles for article (PubMed ID: 29517035)
21. Making gene editing a therapeutic reality.
Conboy I; Murthy N; Etienne J; Robinson Z
F1000Res; 2018; 7():. PubMed ID: 30613384
[TBL] [Abstract][Full Text] [Related]
22. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
Agabiti Rosei E; Salvetti M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
[TBL] [Abstract][Full Text] [Related]
23. Rewriting DNA in the body lowers cholesterol.
Kaiser J
Science; 2023 Nov; 382(6672):751. PubMed ID: 37972155
[TBL] [Abstract][Full Text] [Related]
24. How CRISPR gene editing could help treat Alzheimer's.
Thompson T
Nature; 2024 Jan; 625(7993):13-14. PubMed ID: 38082131
[No Abstract] [Full Text] [Related]
25. Genetic engineering: In vivo genome editing - growing in strength.
Koch L
Nat Rev Genet; 2016 Mar; 17(3):124. PubMed ID: 26781811
[No Abstract] [Full Text] [Related]
26. Triple-Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases.
Zhang L; Wang L; Xie Y; Wang P; Deng S; Qin A; Zhang J; Yu X; Zheng W; Jiang X
Angew Chem Int Ed Engl; 2019 Sep; 58(36):12404-12408. PubMed ID: 31318118
[TBL] [Abstract][Full Text] [Related]
27. CRISPR 'cousin' put to the test in landmark heart-disease trial.
Ledford H
Nature; 2022 Jul; 607(7920):647. PubMed ID: 35840676
[No Abstract] [Full Text] [Related]
28. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
Carlson B
Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
[No Abstract] [Full Text] [Related]
29. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD.
Wang JZ; Wu P; Shi ZM; Xu YL; Liu ZJ
Brain Dev; 2017 Aug; 39(7):547-556. PubMed ID: 28390761
[TBL] [Abstract][Full Text] [Related]
30. Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Amoasii L; Long C; Li H; Mireault AA; Shelton JM; Sanchez-Ortiz E; McAnally JR; Bhattacharyya S; Schmidt F; Grimm D; Hauschka SD; Bassel-Duby R; Olson EN
Sci Transl Med; 2017 Nov; 9(418):. PubMed ID: 29187645
[TBL] [Abstract][Full Text] [Related]
31. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy.
Ryu SM; Koo T; Kim K; Lim K; Baek G; Kim ST; Kim HS; Kim DE; Lee H; Chung E; Kim JS
Nat Biotechnol; 2018 Jul; 36(6):536-539. PubMed ID: 29702637
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia.
Ascaso JF
Endocrinol Nutr; 2016; 63(6):255-7. PubMed ID: 27050861
[No Abstract] [Full Text] [Related]
33. Gene editing based hearing impairment research and therapeutics.
Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
[TBL] [Abstract][Full Text] [Related]
34. CRISPR base editing lowers cholesterol in monkeys.
van Kampen SJ; van Rooij E
Nat Biotechnol; 2021 Aug; 39(8):920-921. PubMed ID: 34168346
[No Abstract] [Full Text] [Related]
35. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
Castillo A
Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
[No Abstract] [Full Text] [Related]
36. In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.
Liao HK; Hatanaka F; Araoka T; Reddy P; Wu MZ; Sui Y; Yamauchi T; Sakurai M; O'Keefe DD; Núñez-Delicado E; Guillen P; Campistol JM; Wu CJ; Lu LF; Esteban CR; Izpisua Belmonte JC
Cell; 2017 Dec; 171(7):1495-1507.e15. PubMed ID: 29224783
[TBL] [Abstract][Full Text] [Related]
37. [Development of novel therapeutic approaches for Duchenne muscular dystrophy].
Takeshima Y
No To Hattatsu; 2014 Mar; 46(2):109-14. PubMed ID: 24738186
[No Abstract] [Full Text] [Related]
38. The CRISPR Way to Think about Duchenne's.
Calos MP
N Engl J Med; 2016 Apr; 374(17):1684-6. PubMed ID: 27119241
[No Abstract] [Full Text] [Related]
39. [The Emeritus Dinosaur's viewpoint - The road to hell of gene therapists is paved with POC].
Kaplan JC
Med Sci (Paris); 2015 Nov; 31 Spec No 3():41-4. PubMed ID: 26546933
[No Abstract] [Full Text] [Related]
40. [CRISPR-Cas9 for muscle dystrophies].
Ballouhey O; Bartoli M; Levy N
Med Sci (Paris); 2020 Apr; 36(4):358-366. PubMed ID: 32356712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
